SGLT-2 inhibitor is likely to be the future treatment of diabetes, a new breakthrough.

SGLT - 2抑制剂很可能是未来糖尿病治疗的一个新的突破口。

youdao

Despite these positive attributes, we have modest expectations for Invokana and the SGLT-2 class because the drug and class are associated with a relatively high rate of genital infections which will limit uptake in our view.

FORBES: Analyst: Higher Rate Of Genital Fungal Infections Could Curb Sales Of New J&J Drug